[{"AccountsPayableCurrent_0_Q1_USD":10614000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":2352000.0,"ShortTermInvestments_0_Q1_USD":193112000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":58065000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q1_USD":192171000.0,"AvailableForSaleSecurities_0_Q1_USD":193112000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":15.67,"PaymentsToAcquireAvailableForSaleSecurities_1_Q1_USD":12923000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":692000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q1_shares":11458.0,"AvailableForSaleSecuritiesCurrent_0_Q1_USD":193112000.0,"InvestmentIncomeInterest_1_Q1_USD":1215000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":252000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-68903000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":39924000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1675000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":4364000.0,"SecurityDeposit_0_Q1_USD":5500000.0,"OtherAssetsNoncurrent_0_Q1_USD":3480000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":3951000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q1_USD":4123000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":4118000.0,"AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_1_Q1_USD":-118000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q1_USD":9412000.0,"RestrictedCash_0_Q1_USD":5525000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":113665000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":118000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.075,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q1_USD":5208000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":9305000.0,"OperatingLeasePayments_1_Q1_USD":2200000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":9412000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3088000.0,"OperatingLeaseLiability_0_Q1_USD":9519000.0,"OperatingLeaseCost_1_Q1_USD":1636000.0,"LettersOfCreditOutstandingAmount_0_Q1_USD":1000000.0,"LeaseCost_1_Q1_USD":3024000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":38646000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":251200000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":912000.0,"AssetsFairValueDisclosure_0_Q1_USD":193112000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":6431000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q1_USD":342000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q1_USD":269000.0,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_Q1_USD":253000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":3833000.0,"LiabilitiesNoncurrent_0_Q1_USD":5440000.0,"LiabilitiesCurrent_0_Q1_USD":39545000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":288298000.0,"Liabilities_0_Q1_USD":44985000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1316000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-7768000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":13858000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":100105000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.55,"CommonStockSharesOutstanding_0_Q1_shares":126823156.0,"CommonStockSharesIssued_0_Q1_shares":126823156.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":52540000.0,"AssetsCurrent_0_Q1_USD":256381000.0,"Assets_0_Q1_USD":288298000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":15826476.0,"AdditionalPaidInCapital_0_Q1_USD":882599000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":912000.0,"CommonStockValue_0_Q1_USD":5000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-65292000.0,"NetIncomeLoss_1_Q1_USD":-69595000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":637000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q1_USD":10195000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":-50000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":3951000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0183,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.6999,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensation_1_Q1_USD":9412000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":56952000.0,"OperatingIncomeLoss_1_Q1_USD":-70810000.0,"OperatingExpenses_1_Q1_USD":70810000.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":22500000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":126568.0,"StockholdersEquity_0_Q1_USD":243313000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-640207000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":13607000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":10729000.0,"ShortTermLeaseCost_1_Q1_USD":17000.0,"VariableLeaseCost_1_Q1_USD":1371000.0,"Ticker":"IOVA","CIK":"1425205","name":"IOVANCE BIOTHERAPEUTICS, INC.","OfficialName":"Iovance Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2593277297.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200505"}]